Literature DB >> 24718744

[Consensus paper of the German Migraine and Headache Society on the structure of headache care facilities in Germany].

M Marziniak1, V Malzacher, S Förderreuther, T Jürgens, P Kropp, A May, A Straube.   

Abstract

This consensus paper introduces a classification of headache care facilities on behalf of the German Migraine and Headache Society. This classification is based on the recommendations of the International Association for the Study of Pain (IASP) and the European Headache Federation (EHF) and was adapted to reflect the specific situation of headache care in Germany. It defines three levels of headache care: headache practitioner (level 1), headache outpatient clinic (level 2) and headache centers (level 3). The objective of the publication is to define and establish reliable criteria in the field of headache care in Germany.

Entities:  

Mesh:

Year:  2014        PMID: 24718744     DOI: 10.1007/s00482-014-1417-3

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  10 in total

Review 1.  Integrated headache care.

Authors:  H-C Diener; C Gaul; R Jensen; H Göbel; A Heinze; S D Silberstein
Journal:  Cephalalgia       Date:  2011-06-02       Impact factor: 6.292

2.  Cost of migraine and other headaches in Europe.

Authors:  J Berg; L J Stovner
Journal:  Eur J Neurol       Date:  2005-06       Impact factor: 6.089

Review 3.  [Recommendations on classification of German pain treatment services].

Authors:  R Sabatowski; C Maier; A Willweber-Strumpf; M Thomm; P Nilges; H Kayser; R Casser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

4.  Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.

Authors:  Thomas-Martin Wallasch; Andreas Angeli; Peter Kropp
Journal:  Headache       Date:  2012-06-15       Impact factor: 5.887

5.  Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.

Authors:  C F Dobson; Y Tohyama; M Diksic; E Hamel
Journal:  Cephalalgia       Date:  2004-01       Impact factor: 6.292

6.  [Development and implementation of integrated health care in pain medicine : the nationwide German headache treatment network].

Authors:  H Göbel; A Heinze; K Heinze-Kuhn; K Henkel; A Roth; H-H Rüschmann
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

7.  Employment and work impact of chronic migraine and episodic migraine.

Authors:  Walter F Stewart; G Craig Wood; Aubrey Manack; Sepideh F Varon; Dawn C Buse; Richard B Lipton
Journal:  J Occup Environ Med       Date:  2010-01       Impact factor: 2.162

8.  Recommendations for headache service organisation and delivery in Europe.

Authors:  T J Steiner; F Antonaci; R Jensen; M J A Lainez; M Lanteri-Minet; D Valade
Journal:  J Headache Pain       Date:  2011-03-05       Impact factor: 7.277

9.  Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study.

Authors:  Charly Gaul; Christina van Doorn; Nadine Webering; Martha Dlugaj; Zaza Katsarava; Hans-Christoph Diener; Günther Fritsche
Journal:  J Headache Pain       Date:  2011-05-05       Impact factor: 7.277

10.  Attitudes towards complementary and alternative medicine in chronic pain syndromes: a questionnaire-based comparison between primary headache and low back pain.

Authors:  Charly Gaul; Thomas Schmidt; Eva Czaja; Regina Eismann; Stephan Zierz
Journal:  BMC Complement Altern Med       Date:  2011-10-07       Impact factor: 3.659

  10 in total
  2 in total

Review 1.  [Pain - a neglected neurological issue].

Authors:  F Birklein; R Baron; C Gaul; C Maihöfner; O Rommel; A Straube; T Tölle; G Wasner
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

Review 2.  [Headache. Current status of research and treatment].

Authors:  A Straube; C Gaul
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.